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http:WHAT THIS PAPER ADDS
The considerable increase of endovascular procedures to treat aneurysmal and occlusive vascular disease over
the last few years has led to increased radiation exposure in patients and staff. This study shows that a new
imaging technology in the hybrid operating room suite can signiﬁcantly reduce radiation dose for both patients
and staff, without changing standard ways of working.Objective/Background: To prospectively quantify radiation dose change in aortoiliac endovascular procedures in
the hybrid operating room (OR) for patients and medical staff with a novel X-ray imaging technology (ClarityIQ
technology), and to assess whether procedure or ﬂuoroscopy time or dose of iodinated contrast was affected.
Methods: A prospective study including 138 patients was performed to compare radiation dose before and after
installation of a novel X-ray imaging technology. Endovascular aneurysm repair (EVAR) was performed in 37
patients and an endovascular procedure for aortoiliac occlusive disease (AIOD) in 101. Patient radiation dose in
air kerma (AK) and dose area product (DAP), patient demographics, and procedural data were recorded. Staff
radiation dose was measured with real time personal dosimetry measurements. In both the EVAR and AIOD
groups the reference system, ALX (AlluraXper FD20; Philips Healthcare, Best, the Netherlands), was compared
with the upgraded X-ray system, CIQ (AlluraClarity FD20; Philips Healthcare). Procedure time, ﬂuoroscopy time,
and iodinated contrast dose were recorded.
Results: Patient radiation dose reduction in the EVAR group, in median AK, was 56% (ALX ¼ 1,262.5 mGy;
CIQ ¼ 556.0 mGy [p < .01]); and in median DAP it was 57% (ALX ¼ 224.4 Gycm2 and CIQ ¼ 95.8 Gycm2
[p < .01]). Patient radiation dose reduction in the AIOD group, in median AK, was 76% (ALX ¼ 1,011.0 mGy;
CIQ ¼ 248.0 mGy [p < .01]); and in median DAP it was 73% (ALX ¼ 138.1 Gycm2; CIQ ¼ 38.0 Gycm2 [p < .01]).
Staff dose reduction in the EVAR group was 16% (ALX ¼ 70.1 mSv; CIQ ¼ 59.2 mSv [p ¼ .43]) and in the AIOD
group it was 69% (ALX ¼ 96.2 mSv; CIQ ¼ 30.1 mSv [p < .01]). There was no statistically signiﬁcant difference
between patient demographics, procedure time, ﬂuoroscopy time, and iodinated contrast medium use in the two
treatment groups before and after installation.
Conclusion: A novel X-ray imaging technology in the hybrid OR suite resulted in a signiﬁcant reduction of patient
and staff radiation dose without affecting procedure length, ﬂuoroscopy time, or use of contrast.
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Over the last few years there has been a signiﬁcant increase
in endovascular procedures for occlusive and aneurysmal
vascular disease.1e4 This increase has been driven by de-
mographic changes and the innovation of endovascularresponding author.
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//dx.doi.org/10.1016/j.ejvs.2015.06.025techniques and materials.5 The increase in the number of
endovascular procedures performed will subsequently lead
to increased exposure of patients and staff to radiation.
The introduction of the hybrid operating room (OR) suite,
an OR that combines state of the art imaging of a ﬁxed large
detector angiographic system with optimal patient care and
the sterility of the OR, has enabled vascular surgeons to
perform (complex) endovascular procedures, as well as to
combine open and endovascular techniques.6,7
The high image quality in the hybrid OR suite, achieved
with ﬁxed X-ray equipment and a large detector, leads to a
higher dose of radiation being administered than with
mobile systems.8 Apart from exposure to radiation during
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patients during work up and follow up also imposes radia-
tion on the patient.9 The exposure of vascular surgeons,
other interventionalists, and patients to radiation during
vascular procedures has been reported previously,10,11 and
it is well known that radiation exposure can lead to harmful
effects.
The importance of radiation protection cannot be over-
stated and the “as low as reasonably achievable” (ALARA)
principle, aimed at reducing radiation exposure should al-
ways be applied. Radiation dose can be reduced by
increasing awareness among personnel and implementing
standardized X-ray exposure protocols. Important steps to
reducing radiation exposure are maximizing the distance
between the X-ray source and the patient, and minimizing
the distance from the patient to the detector.12 Low ﬂuo-
roscopy settings and a clinically appropriate X-ray ﬁeld of
view should be applied.13 Furthermore, the use of road
mapping functionalities and operator controlled imaging
shortens the duration of X-ray activation, leading to a dose
reduction in radiation.14
Lowering the radiation dose in patients will result in a
lower radiation dose to staff.15 Staff radiation dose can be
lowered further by taking protective measures that consist
of various forms of X-ray shielding such as table shielding
and wearing lead aprons, lead collars, and lead glasses.
Moreover, recent technical innovations of the imaging
system could reduce the entrance dose while maintaining
the image quality by means of image processing software
and hardware innovations. This is enabled by advanced real
time image processing algorithms and hardware changes,
such as more copper ﬁltration, shorter pulse duration,
smaller focal spot size, and a more sensitive detector.
Increased computational power enables real time image
processing of an, in general, poor quality raw image.
The main objective of this study was to prospectively
quantify radiation dose change in aortoiliac endovascular
procedures in the hybrid OR suite for patients and medical
staff with a novel X-ray imaging technology based on the
principles mentioned above (ClarityIQ and Allura Clarity,
Philips Healthcare, Best, the Netherlands), and to assess
whether the procedure or ﬂuoroscopy time, or dose of
iodinated contrast was affected.METHODS
Anticipating an upgrade of the X-ray system in the authors’
hybrid OR suite, a study to quantify patient and staff radi-
ation dose was set up. All endovascular aneurysm repair
(EVAR) and endovascular or hybrid repair of aortoiliac
occlusive disease (AIOD) procedures performed in the
hybrid OR suite were included in the study protocol in the
period June 2012eJuly 2013. Approval for the study was
requested but the institutional ethics review committee did
not deem it a necessity. All recorded data were prospec-
tively collected as a standard operating procedure before
and after the study. The update to ClarityIQ was a planned
procedure. The data were used to assess the impact of theinstallation of this latest technology. All examinations were
performed on the same ﬂat panel detector angiography
system (AlluraXper FD20; henceforth “ALX”). The pro-
cedures were performed according to standard practice by
the same group of vascular surgeons, and the same pro-
cedural techniques and workﬂow were used throughout the
study period. From June to September 2012 procedures
were performed with the reference system (ALX) and in the
period October 2012eJuly 2013 with the upgraded system
(AlluraClarity with ClarityIQ technology; henceforth “CIQ”).
CIQ uses advanced image noise reduction algorithms com-
bined with hardware changes (beam ﬁltration, focal spot
size, pulse width, detector, and image processing engine)
and optimized system settings to enable dose reduction for
digital subtraction angiography (DSA) and ﬂuoroscopy.
Procedural and radiation dose data of the EVAR and AIOD
procedures performed before and after the upgrade of the
system were collected prospectively. In both groups the
reference ALX system and the upgraded CIQ system were
compared. Interventions were performed with local,
regional, or general anesthesia tailored to the patient’s
needs. Collected patient data included age, sex, height, and
weight. Procedural details recorded were procedure time,
ﬂuoroscopy time, and total dose of iodinated contrast
(Omnipaque 300; GE Healthcare B.V., Eindhoven, the
Netherlands).
Radiation dose was assessed with both dose area product
(DAP) and air kerma (AK) measurements. DAP (Gycm2) is
deﬁned as the product of the surface area of the patient
that is exposed to radiation at the skin entrance area (in
cm2) multiplied by the radiation dose at this surface in
Joules per kg (Gy). AK, the kinetic energy released per unit
mass air, describes the energy transferred by radiation in
Gy. Although kerma is a different measure than dose, for
practical radiation protection scenarios the measures can be
considered numerically equivalent (AK z Dtissue).
Standard pre-procedural work up did not change after
the upgrade. For the EVAR procedures CT angiography was
performed in both groups and no additional CT scans were
done. Standard pre-procedural imaging for AIOD was done
with magnetic resonance angiography.
Staff radiation exposure was measured with an electronic
personal dosimeter (EPD) (DoseAware; Philips Healthcare).
The electronic dose meters record dose rate per second and
cumulative dose, expressed as personal dose equivalent
values Hp(10).16 EPDs were positioned on the outside of the
thyroid collar of the vascular surgeon, anesthesiology nurse,
and theatre nurse. In case of multiple physicians performing
the procedure the highest radiation exposure reading was
used.
Statistical analysis was done using SAS/STAR version 9.3
(SAS Institute Inc., Cary, NC, USA). Analysis was accom-
plished using the SAS mixed model approach. The dose data
were tested for homogeneity using the ShapiroeWilk test
for normality. If the assumptions of homogeneity of vari-
ance and normality required for the mixed model analysis
described above (i.e., the data were highly skewed, with
unequal variance) were violated, a sensitivity analysis was
Table 1. Patient demographics.
Characteristic Treatment groups Total pa
Reference system (ALX) Upgraded system (CIQ)
EVAR
Patients (n) 18 19 37
Female 3 (17) 0 (0) 3 (8) .73
Male 15 (83) 19 (100) 34 (92)
Age, y (mean  SD) 70.8  5.7 69.5  8.9 70.1  7.5 .63
Height, cm (mean  SD) 174.8  10.6 176.3  6.7 175.6  8.7 .63
Weight, kg (mean  SD) 84.3  17.2 83.3  14.1 83.8  15.5 .85
BMI, kg/m2 (mean  SD) 27.6  5.2 26.9  4.5 27.2  4.8 .66
AIOD
Patients (n) 34 67 101
Female 15 (44) 21 (31) 36 (36) .21
Male 19 (56) 46 (69) 65 (64)
Age, y (mean  SD) 62.5  8.7 62.1  11.4 62.2  10.5 .83
Height, cm (mean  SD) 171.0  9.3 172.9  9.2 172.2  9.3 .33
Weight, kg (mean  SD) 75.5  14.1 75.9  15.2 75.8  14.8 .90
BMI, kg/m2 (mean  SD) 25.9  4.7 25.3  4.3 25.5  4.4 .56
Note. Data are n (%) unless otherwise indicated. ALX ¼ AlluraXper FD20 (Philips Healthcare, Best, the Netherlands); CIQ ¼ AlluraClarity
FD20 (Philips Healthcare); EVAR ¼ endovascular aneurysm repair; BMI ¼ body mass index; AIOD ¼ aortoiliac occlusive disease.
a p-value (two sided) from analysis of variance for continuous parameters and from chi-square test for categorical parameters.
482 R.F.F. van den Haak et al.performed using log-transformed data and a non-
parametric Wilcoxon two-sample test procedure. Compari-
sons of the patient demographics and procedure descrip-
tion between the two treatment groups before and after
the system upgrade (ALX vs. CIQ) were performed using an
F-test obtained from an analysis of variance for continuous
variables, and a chi-square test for categorical variables.
RESULTS
In this prospective analysis 138 patients were included: 37
were treated for an abdominal aortic aneurysm with EVAR
and 101 were treated for AIOD. All patients underwent
therapeutic procedures. All EVAR procedures were standard
infrarenal procedures. The AIOD procedures varied from
simple iliac percutaneous transluminal angioplasty to re-
canalizations, and therefore this was a heterogeneous
group containing no subgroups. No statistically signiﬁcant
differences regarding age, sex, height, or body mass indexTable 2. Patient radiation: air kerma (AK) and dose area product (DAP
Radiation parameter Treatment groups
Reference system (ALX) Upg
EVAR
Patients (n) 18 19
AK, mGy (median) 1262.5 556
75th percentile 1383.4 868
DAP, Gycm2 (median) 224.4 95.
75th percentile 275.0 166
AIOD
Patients (n) 34 67
AK, mGy (median) 1011.0 248
75th percentile 1564.7 446
DAP, Gycm2 (median) 138.1 38.
75th Percentile 276.4 56.
Note. ALX ¼ AlluraXper FD20 (Philips Healthcare, Best, the N
EVAR ¼ endovascular aneurysm repair; AIOD ¼ aortoiliac occlusive di
a Wilcoxon two sample test.(BMI); p > .05 were found between the two patient groups
before or after the upgrade (Table 1).
The mean age of patients in the EVAR group was 70.1
years (range 54.0e83.0 years), and the mean BMI of these
patients was 27.2 kg/m2 (range 20.0e36.7 kg/m2).
In the EVAR group, the procedures performed with CIQ
showed a signiﬁcant reduction in radiation dose versus those
performed with ALX. This reduction, based on median DAP,
was 57.3% (ALX¼ 224.4 Gycm2; CIQ¼ 95.8 Gycm2 [p< .01]);
based on median AK it was 56.0% (ALX ¼ 1262.5 mGy;
CIQ ¼ 556.0 mGy [p ¼ .01]) (see Table 2 and Fig. 1).
The mean age of patients in the AIOD group was 62.2
years (range 42.0e86.0 years), and their mean BMI was
25.5 kg/m2 (range 16.2e41.4 kg/m2).
A signiﬁcant dose reduction was also measured in the
AIOD group for the procedures performed with CIQ versus
ALX. Based on median DAP, the reduction was 72.5%
(ALX ¼ 138.1 Gycm2; CIQ ¼ 38.0 Gycm2 [p < .01]) and,).
Dose reduction (%) pa
raded system (CIQ)
.0 56.0 <.01
.6 37.2
8 57.3 <.01
.6 39.4
.0 75.5 <.01
.0 71.5
0 72.5 <.01
4 79.6
etherlands); CIQ ¼ AlluraClarity FD20 (Philips Healthcare);
sease.
Figure 1. Radiation dose by procedure - DAP (Gycm2).
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CIQ ¼ 248.0 mGy [p < .01]) (see Table 2 and Fig. 1).
Staff radiation dose was not normally distributed (see
Fig. 2). The range of the radiation dose median values for
vascular surgeons was 30.1e96.2 mSv, for theatre nurses it
was 3.9e11.1 mSv, and for anesthesiology nurses it was
1.2e5.2 mSv.
In the EVAR group the dose reduction for the vascular
surgeon achieved with CIQ, based on median dose level,
was 15.5% (ALX ¼ 70.1 mSv; CIQ ¼ 59.2 mSv [p ¼ .43]); in
the AIOD group it was 68.7% (ALX ¼ 96.2 mSv;
CIQ ¼ 30.1 mSv [p < .01]). Details on staff radiation dose
are presented in Table 3.
With regard to total procedure time, ﬂuoroscopy time,
and the amount of contrast used, no statistically signiﬁcant
difference was found in either the EVAR or AIOD groups,
before or after the upgrade. The results are presented in
Table 4. The image quality, both before and after the
installation, was perceived by the vascular surgeons to be
clinically adequate with high detail.Figure 2. Radiation dose by occupation - DAP (Gycm2).DISCUSSION
The results obtained herein show a substantial reduction in
the dose of radiation to patients and staff in the hybrid OR
suite after the introduction of the new CIQ technology
without having to change the standard way of working.
In this study, a dose reduction of 72.5% was found after
introducing CIQ, based upon DAP measurements in the pa-
tient group treated for AIOD. The reduction achieved for the
smaller EVAR group was also signiﬁcant (57.0%). A possible
explanation for this somewhat smaller patient dose reduction
lies in the way EVAR procedures are performed. To achieve a
perpendicular view of the aortic neck and iliac vessels cranio-
caudal and oblique C-arm angulations are more frequently
applied for DSA imaging.With these angulated settings, the X-
rays need to travel longer distances through the patient,
leading to an increased patient radiation dose.
In this series, the median patient radiation dose (DAP)
was 138 Gycm2 for AIOD procedures before the system
upgrade, which is comparable with data reported by Miller
et al.17 A Median DAP value of 224 Gycm2 for EVAR pro-
cedures performed before the upgrade are comparable with
ﬁndings reported by Weerakkody et al.,18 Walsh et al.,19
and Kalef-Ezra et al.20 The median DAP values for the
EVAR procedures after the system upgrade are in line with
values of current mobile systems with a small detector.21
The upgraded ﬁxed X-ray CIQ system offers the advan-
tages of a ﬁxed system, such as a large ﬁeld of view, high
image quality, ease of workﬂow, and resistance to over-
heating of the X-ray source, without the usual disadvantage
of a high dose of radiation being administered by a ﬁxed
system compared with a mobile C-arm system.
Emphasis has always been placed on patient radiation
dose. Although this general principle is highly important,
the relatively short life expectancy of this group of patients
will make long-term radiation effects less likely to occur.22
Hybrid OR personnel face lifelong exposure to potentially
harmful radiation. Therefore, achieving a reduction in radi-
ation dose to protect staff could be of even more impor-
tance than a dose reduction in patients. Given the current
level of patient and staff exposure, measures should be
taken to protect staff from the long-term effects of radia-
tion and to maintain awareness that there is no such thing
as a safe dose of radiation or a safety threshold.
A substantial staff radiation dose reduction of 68.7% was
found in the AIOD treatment group. This result is compa-
rable with the patient radiation dose reduction (DAP) of
72.5% in this treatment group. In the EVAR group the staff
radiation dose reduction after the upgrade was lower and
was not statistically different. Apart from the smaller group
size, the 15.0% staff dose reduction could be explained by
several other factors. The main factor may be that these
procedures are different from those carried out in the AIOD
group because of the frequent use of X-ray source angula-
tions, as mentioned previously. X-ray source angulation,
which was not recorded in the study protocol, creates less
favorable patterns of radiation scatter; for cranio-caudal
projections, in particular, these patterns might contribute
Table 4. Procedure description.
Characteristics Category Treatment Total pa
Reference system (ALX) Upgraded system (CIQ)
EVAR
Patients (n) 18 19 37
Total procedure duration (min) 99.12  38.88 91.26  29.97 94.97  34.19 .50
Fluoroscopy time (min) 13.56  8.55 13.10  6.09 13.33  7.32 .86
Contrast used (mL) 69.65  39.04 60.19  21.28 64.79  31.09 .38
AIOD
Patients (n) 34 67 101
Total procedure duration (min) 72.44  46.77 87.63  57.68 82.51  54.49 .19
Fluoroscopy time (min) 9.82  11.27 6.51  6.80 7.62  8.65 .07
Contrast used (mL) 57.12  26.73 52.28  27.89 53.91  27.47 .41
Note. Data are mean  SD unless otherwise indicated.
a p-value (two sided) from analysis of variance for continuous variables and from chi-square test for categorical variables.
Table 3. Staff radiation dose.
Procedure Treatment group Dose reduction (%) pa
Reference system (ALX) Upgraded system (CIQ)
AIOD
Vascular surgeons (n) 34 65
Median 96.2 30.1 68.7 <.01
75th percentile 160.8 49.3 69.3
EVAR
Vascular surgeons (n) 17 19
Median 70.1 59.2 15.5 .73
75th percentile 173.3 140.4 19.0
AIOD
Anesthetic nurses (n) 26 27
Median 3.2 1.2 62.5 <.01
75th percentile 8.3 2.2 73.5
EVAR
Anesthetic nurses (n) 15 10
Median 5.2 3.1 40.4 .08
75th percentile 10.9 3.8 65.1
AIOD
Theatre nurses (n) 34 61
Median 10.8 3.9 63.9 <.01
75th percentile 23.3 8.3 64.4
EVAR
Theatre nurses (n) 16 17
Median 11.1 5.2 53.2 .24
75th percentile 13.7 13.4 2.2
Note. ALX ¼ AlluraXper FD20 (Philips Healthcare, Best, the Netherlands); CIQ ¼ AlluraClarity FD20 (Philips Healthcare); AIOD ¼ aortoiliac
occlusive disease; EVAR ¼ endovascular aneurysm repair.
a Wilcoxon two sample test.
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cedures were sometimes performed with two vascular
surgeons, from whom the highest personal dose was
recorded. Surgeon position relative to the X-ray source and
shielding (e.g., position at the operating table) was not
recorded in the study protocol. On the C-arm side of the
table no shielding curtains were installed, potentially lead-
ing to the highest dose reading being obtained by the
assisting surgeon, who would be in this position and not the
leading vascular surgeon.
Another ﬁnding was that radiation dose for other hybrid
OR suite personnel (range 1.2e11.1 mSv) was almost 10 fold
lower than the dose received by the vascular surgeon(range 30.1e96.2 mSv). For the theatre nurse the most likely
cause is shielding by the vascular surgeon, who stands to
the left of the nurse and is closer to the X-ray source. The
increased distance from the source of the scatter radiation
also contributes to the lower dose of radiation. For the
anesthesiology nurse this lower dose can be explained by
the standard use of a mobile lead shielding screen unit in
the OR, which is placed at the head end of the OR table and
thus protects the anesthesiology nurse from radiation. Us-
ing this set up, the theatre and anesthesiology nurses
receive lower radiation doses.
Apart from reducing the amount of radiation produced,
alternative methods of radiation dose reduction for staff
Signiﬁcant Radiation Dose Reduction 485include increasing the distance to the source of the radia-
tion or the use of extensive shielding with screens or drapes
containing X-ray-absorbing materials. Recently, a random-
ized study by Kloeze et al. involving the use of radiation
absorbing surgical drapes resulted in a 55% reduction in
radiation dose for the interventionalist.23 However, these
methods do not reduce the dose of radiation to the patient,
are often made disposable by design, and need to be re-
installed before every procedure. Therefore, lowering the
patient entry dose seems more appropriate to reduce ra-
diation exposure to all persons involved.
Dose reduction may carry the risk of deterioration in
image quality. Image quality assessment is possible by the
use of image quality phantoms. Given the nature of how
dose reduction is achieved by CIQ it is difﬁcult to apply the
standard method of image quality assessment to this
technique. Therefore, it is difﬁcult to translate the results
obtained in the clinical situation to this situation and vice
versa. Ideally, although still subjective, image quality eval-
uation is performed through a clinical trial using standard-
ized quality scoring criteria.24
In the present study image quality was assessed by
measuring three variables: procedure time, ﬂuoroscopy
time, and iodinated contrast medium use. These parameters
were used as surrogate end points for clinical image quality,
assuming that lower image quality would lead to longer
procedure and ﬂuoroscopy time, and use of larger volumes
of contrast medium. No increase was found in procedure or
ﬂuoroscopy time to compensate for this theoretical disad-
vantage of reduced image quality. Furthermore, contrast
medium use did not increase, indicating that no additional
DSA runs were taken. With ALX the image quality was
perceived as clinically sufﬁcient. After the upgrade to CIQ,
image quality was perceived to be of high detail and more
than sufﬁcient for clinical use.
The radiation dose reduction measured in this study is
based solely on technical changes to the X-ray system. There
was no alteration of the workﬂow or procedures used.21
Future work can focus on further radiation dose reduction
achieved by changing the workﬂow or procedures, or by
adjusting system settings. The latter could affect image
quality but whether this poses a clinical problem needs to
be investigated.
The limits for acceptable staff radiation exposure are partly
based on achievable minimal radiation dose with the current
technical possibilities. The introduction of new types of de-
tector and post-processing algorithms will probably reduce
radiation exposure further. If technological developments
lead to substantial reproducible radiation reduction in
medical practice it can be expected that these allowable
limits will be lowered to adhere to the ALARA principles.CONCLUSION
A novel X-ray imaging technology in a hybrid OR suite
resulted in a signiﬁcant reduction of patient and staff ra-
diation dose without affecting procedure length, ﬂuoros-
copy time, or contrast use.CONFLICT OF INTEREST
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